Targeting mTOR pathway: A new concept in cancer therapy

Por Advani, S. H.
Publicado em 2010

Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010

Por Bansal, Shweta, Advani, S. H.
Publicado em 2013

Bruton’s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib

Por Aalipour, Amin, Advani, Ranjana H.
Publicado em 2014

Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas

Por Aalipour, Amin, Advani, Ranjana H.
Publicado no Br J Haematol (2013)

Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.

Por Mukhopadhyaya, R., Advani, S. H., Gangal, S. G.
Publicado em 1987

Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.

Por Somasundaram, R., Advani, S. H., Gangal, S. G.
Publicado em 1983

In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.

Por Khare, A. G., Advani, S. H., Gangal, S. G.
Publicado em 1981

Current concepts and controversies in the management of early stage Hodgkin lymphoma

Por Maeda, Lauren S., Lee, Mark, Advani, Ranjana H.
Publicado no Leuk Lymphoma (2011)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia

Por Advani, S. H., Achreckar, Suvarna, Thomas, Dennis, Krishnankutty, Binny
Publicado em 2010

Altered Ca(2+ )homeostasis in polymorphonuclear leukocytes from chronic myeloid leukaemia patients

Por Revankar, Chetana M, Advani, Suresh H, Naik, Nishigandha R
Publicado em 2006

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

Por Rajaram, N., Tatake, R. J., Advani, S. H., Gangal, S. G.
Publicado em 1990

Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.

Por Gangal, S. G., Gothoskar, B. P., Joshi, C. S., Advani, S. H.
Publicado em 1976

Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

Por Damle, R. N., Tatake, R. J., Advani, S. H., Gangal, S. G.
Publicado em 1990

Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.

Por Gangal, S. G., Damle, N. K., Khare, A. G., Advani, S. H.
Publicado em 1979

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Por Ahuja, H, Bar-Eli, M, Advani, S H, Benchimol, S, Cline, M J
Publicado em 1989

Kodameae ohmeri – An Emerging Yeast: Two Cases and Literature Review

Por Biswal, Debadulal, Sahu, Manisa, Mahajan, Asmita, Advani, Suresh H, Shah, Suresh
Publicado no J Clin Diagn Res (2015)

RhoA: A therapeutic target for chronic myeloid leukemia

Por Molli, Poonam R, Pradhan, Madhura B, Advani, Suresh H, Naik, Nishigandha R
Publicado em 2012

Reduced PKC α Activity Induces Senescent Phenotype in Erythrocytes

Por Govekar, Rukmini B., Kawle, Poonam D., Advani, Suresh H., Zingde, Surekha M.
Publicado em 2012

An elderly woman with triple primary metachronous malignancy: A case report and review of literature

Por Takalkar, Unmesh, Asegaonkar, Balaji N., Kodlikeri, Pushpa, Asegaonkar, Shilpa, Sharma, Brijmohan, Advani, Suresh H.
Publicado em 2013

Saree Cancer in Indian Woman Treated Successfully with Multimodality Management

Por Takalkar, Unmesh Vidyadhar, Asegaonkar, Shilpa Balaji, Kodlikeri, Pushpa, Kulkarni, Ujwala, Borundiya, Virendrakumar, Advani, Suresh H.
Publicado no Dermatol Reports (2014)